Last reviewed · How we verify
Probe drugs
At a glance
| Generic name | Probe drugs |
|---|---|
| Sponsor | GlaxoSmithKline |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Study to Evaluate the Effect of Repotrectinib on the Drug Levels of Transporter and CYP P450 Probe Substrates in Healthy Adult Participants (PHASE1)
- Intercostal Nerve Cryoablation Versus Epidural Analgesia for Nuss Repair of Pectus Excavatum (NA)
- The REBALANCE Study - a Prospective, Multicenter, Randomized, Pivotal Study of the May Health System (NA)
- A Novel Intraoperative Fluorescence-guided System for Evaluating Margins During Breast-conserving Surgery for Breast Cancer (NA)
- IMMULAB - Immunotherapy With Pembrolizumab in Combination With Local Ablation in Hepatocellular Carcinoma (HCC) (PHASE2)
- Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies (PHASE4)
- Blood Flow Monitoring to Prevent Post-Polypectomy Induced Ulcer Bleeding (NA)
- Effect of Individually Trained Oral Prophylaxis (iTOP) on Gingival Health in Orthodontic Patients (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |